Sign In
Buy SANA
$3.12
-0.120 (-3.70%)
At Close: Jun 03, 2026
SEATTLE, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the appointment of
Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle
07:12pm, Friday, 02'nd Aug 2024
Sana Biotechnology celebrated the beginning of a new chapter on its journey to make drugs that treat complicated diseases, cutting the ribbon outside the company's new manufacturing facility in Bothel
SANA Stock Earnings: Sana Biotechnology Meets EPS for Q1 2024
10:55pm, Wednesday, 08'th May 2024
Sana Biotechnology (NASDAQ: SANA ) just reported results for the first quarter of 2024. Sana Biotechnology reported earnings per share of -32 cents.
Sana Biotechnology to Present at May and June 2024 Investor Conferences
04:05pm, Monday, 06'th May 2024
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webca
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
08:26am, Friday, 03'rd May 2024
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX
09:02pm, Sunday, 21'st Apr 2024
Biotech stocks are having a relatively strong year as investors focus on the growing M&A in the healthcare space. Johnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
04:05pm, Thursday, 29'th Feb 2024
Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
04:05pm, Wednesday, 28'th Feb 2024
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webc
Insider Buying: Taking a Controlling Stake in a Struggling Retailer?
11:20am, Sunday, 18'th Feb 2024
The biggest insider trading news of the week may have been Amazon.com Inc. (NASDAQ: AMZN) founder Jeff Bezos shedding over $4 billion worth of the company's shares as he reportedly prepares to move to
Transplant of HIP-modified pancreatic islet cells provided lasting glucose control in a fully immunocompetent non-human primate (NHP), enabling the achievement of exogenous insulin independence withou
SEATTLE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has closed
Sana Biotechnology Announces Pricing of Upsized Public Offering
01:22am, Thursday, 08'th Feb 2024
SEATTLE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has priced
Sana Biotechnology Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 07'th Feb 2024
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has commen
Are You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice
01:01pm, Thursday, 18'th Jan 2024
Does Sana Biotechnology (SANA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why
11:27am, Thursday, 18'th Jan 2024
Sana Bio (SANA) rallies 105% after the company reports encouraging pipeline progress with its candidates, SC291 and SC262, for oncology and autoimmune indications.
